Abcellera Biologics Inc.盘中异动大幅拉升5.24%报2.21美元

市场透视2025-05-14

北京时间2025年05月14日21时41分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.21美元/股，成交量33.3572万股，换手率0.11%，振幅4.76%。最近的财报数据显示，该股实现营业收入4.24百万美元，净利润-45.62百万美元，每股收益-0.15美元，毛利-2.37百万美元，市盈率-3.93倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535208030?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-14 21:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535208030","market":"us","top_or_hot":-1,"title":"Abcellera Biologics Inc.盘中异动 大幅拉升5.24%报2.21美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月14日21时41分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.21美元/股，成交量33.3572万股，换手率0.11%，振幅4.76%。最近的财报数据显示，该股实现营业收入4.24百万美元，净利润-45.62百万美元，每股收益-0.15美元，毛利-2.37百万美元，市盈率-3.93倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Abcellera Biologics Inc.盘中异动 大幅拉升5.24%报2.21美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAbcellera Biologics Inc.盘中异动 大幅拉升5.24%报2.21美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-14 21:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月14日21时41分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.21美元/股，成交量33.3572万股，换手率0.11%，振幅4.76%。最近的财报数据显示，该股实现营业收入4.24百万美元，净利润-45.62百万美元，每股收益-0.15美元，毛利-2.37百万美元，市盈率-3.93倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4535","symbol_name":"淡马锡持仓","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b","article_id":"2535208030","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214102a47e4050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535208030","pubTimestamp":1747230061,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月14日21时41分，Abcellera Biologics Inc.股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.21美元/股，成交量33.3572万股，换手率0.11%，振幅4.76%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4535":"淡马锡持仓","BK4121":"生命科学工具和服务","ABCL":"AbCellera Biologics","BK4007":"制药","SEPN":"Septerna, Inc."},"translate_title":"Abcellera Biologics Inc. surged 5.24% to $2.21 in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SEPN":0.82,"ABCL":0.9},"content_text":"北京时间2025年05月14日21时41分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.21美元/股，成交量33.3572万股，换手率0.11%，振幅4.76%。最近的财报数据显示，该股实现营业收入4.24百万美元，净利润-45.62百万美元，每股收益-0.15美元，毛利-2.37百万美元，市盈率-3.93倍。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Septerna, Inc.、蓝鸟生物、Nucana Plc涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2312.94%、1561.48%、1281.10%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 (To Pur Com)、Septerna, Inc.、Nucana Plc，振幅分别为46.33%、26.75%、23.40%。Abcellera Biologics Inc.公司简介：AbCellera Biologics Inc 是一家专门设计用于克服传统发现障碍的抗体发现和开发引擎，能够以更高的精确度和速度找到最佳临床候选药物，更快地用于临床和患者。凭借集成的AbCellera平台，公司的专家能够快速搜索广泛的多样化抗体，挑选出有效且可开发的先导药物，为合作伙伴的持久成功奠定基础。该公司在与新兴生物技术和制药公司建立合作伙伴关系方面拥有丰富经验。AbCellera利用其专有的硬件、软件和工具，结合最新的数据科学，作为战略合作伙伴，帮助任何项目更快地开发出优化的解决方案。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535208030","isCrawlerRequest":true}

Abcellera Biologics Inc.盘中异动 大幅拉升5.24%报2.21美元

精彩评论

Abcellera Biologics Inc.盘中异动大幅拉升5.24%报2.21美元